December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

15.48 -2.99 (-16.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Tandem Diabetes Care Q1 Earnings Call Highlights ↗
Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward... 
Via MarketBeat
Topics Earnings Supply Chain
News headline image
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 10.9% in the afternoon session after the company's disappointing... 
Via StockStory
Topics Artificial Intelligence
News headline image
TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.5% year on ... 
Via StockStory
Tandem Diabetes Care (NASDAQ:TNDM) Surges 10% After Q1 Beat on Revenue and Earnings ↗
Via Chartmill
News headline image
Tandem (TNDM) Q1 2026 Earnings Transcript ↗
Tandem (TNDM) Q1 2026 Earnings Transcript 
Via The Motley Fool
Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Strong Q4 Beat but Issues Cautious 2026 Sales Guidance ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.5% year on year to $247.... 
Via StockStory
Topics Artificial Intelligence
News headline image
Tandem Diabetes (TNDM) Q1 Earnings: What To Expect
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results this Thursday after market hours. Here’s what investors should know.... 
Via StockStory
News headline image
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
Topics Firearms
News headline image
3 Stocks Under $50 Walking a Fine Line
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline... 
Via StockStory
News headline image
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
3 Small-Cap Stocks That Concern Us
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
3 Reasons to Sell TNDM and 1 Stock to Buy Instead
The past six months have been a windfall for Tandem Diabetes’s shareholders. The company’s stock price has jumped 93.6%, hitting $24.34 per share. This was p... 
Via StockStory
Topics Bankruptcy
News headline image
Why Are Tandem Diabetes (TNDM) Shares Soaring Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 7.8% in the afternoon session after investment firm Piper Sand... 
Via StockStory
Topics Economy
News headline image
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
1 Cash-Burning Stock with Promising Prospects and 2 We Avoid
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy
News headline image
Why Tandem Diabetes Care Stock Popped Today ↗
The med tech supplier is shifting to a more predictable and lucrative business model. 
Via The Motley Fool
Topics Supply Chain
News headline image
Why Are Tandem Diabetes (TNDM) Shares Soaring Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 30.2% in the afternoon session after the company reported better-than-expected fourth-quarter financial results. 
Via StockStory
Topics Artificial Intelligence Supply Chain
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? ↗
For the full year, Tandem reported $1.015 billion in worldwide sales and over 126,000 pump shipments. 
Via Stocktwits
Topics Earnings
News headline image
Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. On the other hand, the company’s... 
Via StockStory
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings... 
Via MarketMinute
Topics Earnings
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.